Risk of Cardiovascular and Cerebrovascular Events in Polycystic Ovarian Syndrome Women: A Meta-Analysis of Cohort Studies
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Aim: This systematic review and meta-analysis aimed to investigate the risk of cardiovascular disease (CVD) and cerebrovascular disease (CeVD) events in women with polycystic ovary syndrome (PCOS). Methods: We searched the literatures in Pubmed, Embase, and Web of Science to identify the cohort studies reporting the association between PCOS and CVD/CeVD events from 1964 to June 1, 2020. Outcome variables such as all-cause mortality, cardiovascular death, any cardiovascular diseases, myocardial infarction, ischemic heart disease, and stroke are extracted from the identified literatures and reported the outcomes of the association in hazard ratios (HR) and odds ratios (OR). Results: Ten cohort studies comprising 166,682 samples are included in the review. Compared to non-PCOS women, the pooled risk of CVD events in PCOS women OR: 1.62 (95% CI: 1.34–1.97). In addition, the risk of myocardial infarction (OR: 2.57, 95% CI: 1.37–4.82), ischemic heart disease (OR: 2.77, 95% CI: 2.12–3.61), and stroke (OR: 1.96, 95% CI: 1.56–2.47) are higher in the PCOS group. However, no significant difference in the overall mortality (HR: 1.04, 95% CI: 0.57–1.86) and CVD-related death (HR: 1.49, 95% CI: 0.99–2.23) was observed. Funnel plots of all outcomes were roughly symmetric, and no significant publication bias was found. Conclusion: Through this study identified an increased risk of CVD and CeVD among women with PCOS including occurance of myocardial infarction, ischemic heart disease, and stroke, but no difference in the all cause or CVD related mortality observed. Further large scale studies are warranted to strengthen the association between PCOS and CV events.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
A comprehensive review on metabolic syndrome
Kaur, J. (2014) · Cardiology Research and Practice · doi:10.1155/2014/943162 · Cited by 1,889 · cited 1×
“Changes in intrinsic risk mechanisms, including increased LDL and TG synthesis, enhanced gluconeogenics, decreased lipoprotein lipase activity, decreased liver clearance of LDL and TG, and abnormal lipid metabolism production, lead to obesity in the PCOS population (41).”
BackgroundRetracted(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Das, S. R., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000659 · Cited by 9,036
Criteria, Prevalence, and Phenotypes of Polycystic Ovary Syndrome
Lizneva, D., Suturina, L., Walker, W., Brakta, S., Gavrilova-Jordan, L., & Azziz, R. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.05.003 · Cited by 1,358
Wild, S., Pierpoint, T., McKeigue, P., & Jacobs, H. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01000.x · Cited by 970
Yildiz, B. O., Bozdag, G., Yapici, Z., Esinler, I., & Yarali, H. (2012) · Human Reproduction · doi:10.1093/humrep/des232 · Cited by 704
Deeks, J. J. (2002) · Statistics in Medicine · doi:10.1002/sim.1188 · Cited by 660 · cited 1×
“Statistical Analysis The effect size of hazard ratio (HR) (13) with 95% confidence interval (CI) was used for the outcome of mortality rate, and the odds ratios (OR) (14, 15) with 95% CI was used for the incidence of cardiovascular and cerebrovascular events.”
MethodMeta-analysis, funnel plots and sensitivity analysis
Copas, J. (2000) · Biostatistics · doi:10.1093/biostatistics/1.3.247 · Cited by 503 · cited 1×
“Funnel plots were used to qualitatively detect publication bias (17).”
MethodThe Potential Implications of a PCOS Diagnosis on a Woman's Long-Term Health Using Data Linkage
Hart, R., & Doherty, D. A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3886 · Cited by 391
Complications and challenges associated with polycystic ovary syndrome: current perspectives
Palomba, S., Santagni, S., Falbo, A., & La Sala, G. B. (2015) · International Journal of Women's Health · doi:10.2147/ijwh.s70314 · Cited by 287
Research works printed but not linked: 27
- Azziz, 2004, The prevalence and features of the polycystic ovary syndrome in an unselected population, J Clin Endocrinol Metab, 89, 2745, 10.1210/jc.2003-032046 · DOI · Paper page
- Clayton, 1992, How common are polycystic ovaries in normal women and what is their significance for the fertility of the population?, Clin Endocrinol, 37, 127, 10.1111/j.1365-2265.1992.tb02296.x · DOI · Paper page
- Cibula, 2000, Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome, Hum Reprod., 15, 785, 10.1093/humrep/15.4.785 · DOI · Paper page
- Kinoshita, 1990, Impaired glucose tolerance in patients with polycystic ovary syndrome (PCOS), Horm Res, 33, 18, 10.1159/000181560 · doi:10.1159/000181560
- Bedaiwy, 2018, Clinical, hormonal, and metabolic parameters in women with subclinical hypothyroidism and polycystic ovary syndrome: a cross-sectional study, J Women's Health., 27, 659, 10.1089/jwh.2017.6584 · DOI
- Vatopoulou, 2020, Management of obesity in adolescents with polycystic ovary syndrome. Expert Opin Pharmacother, 21, 1, 10.1080/14656566.2019.1701655 · DOI
- Jiang, 2019, Ceramide subclasses identified as novel lipid biomarker elevated in women with polycystic ovary syndrome: a pilot study employing shotgun lipidomics, Gynecol Endocrinol., 36, 1, 10.1080/09513590.2019.1698026 · DOI
- Jacewicz-Swiecka, 2018, Polycystic ovary syndrome and the risk of cardiometabolic complications in longitudinal studies, Diabetes Metab Res Rev, 34, e3054, 10.1002/dmrr.3054 · DOI · Paper page
- Wang, 2012, Semiparametric hazard function estimation in meta-analysis for time to event data, Res Synth Methods, 3, 240, 10.1002/jrsm.1047 · DOI
- Greenland, 1987, Interpretation and choice of effect measures in epidemiologic analyses, Am J Epidemiol, 125, 761, 10.1093/oxfordjournals.aje.a114593 · DOI · Paper page
- Thompson, 1999, Explaining heterogeneity in meta-analysis: a comparison of methods, Stat Med, 18, 2693, 10.1002/(sici)1097-0258(19991030)18:20<2693::aid-sim235>3.0.co;2-v · doi:10.1002/(sici)1097-0258(19991030)18:20<2693::aid-sim235>3.0.co;2-v
- Calderon-Margalit, 2014, Prospective association of polycystic ovary syndrome with coronary artery calcification and carotid-intima-media thickness: the Coronary Artery Risk Development in Young Adults Women's study, Arterioscler Thromb Vasc Biol, 34, 2688, 10.1161/ATVBAHA.114.304136 · DOI · Paper page
- Dahlgren, 1992, Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women, Acta Obstet Gynecol Scand, 71, 599, 10.3109/00016349209006227 · DOI · Paper page
- Ding, 2018, Coronary artery disease risk in young women with polycystic ovary syndrome, Oncotarget, 9, 8756, 10.18632/oncotarget.23985 · DOI
- Iftikhar, 2012, Risk of cardiovascular events in patients with polycystic ovary syndrome, Neth J Med., 70, 74
- Lo, 2006, Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome, J Clin Endocrinol Metab, 91, 1357, 10.1210/jc.2005-2430 · DOI · Paper page
- Lunde, 2007, Polycystic ovary syndrome: a follow-up study on diabetes mellitus, cardiovascular disease and malignancy 15–25 years after ovarian wedge resection, Gynecol Endocrinol, 23, 704, 10.1080/09513590701705189 · DOI · Paper page
- Mani, 2013, Diabetes and cardiovascular events in women with polycystic ovary syndrome: a 20-year retrospective cohort study, Clin Endocrinol, 78, 926, 10.1111/cen.12068 · DOI · Paper page
- Morgan, 2012, Evaluation of adverse outcome in young women with polycystic ovary syndrome versus matched, reference controls: a retrospective, observational study, J Clin Endocrinol Metab, 97, 3251, 10.1210/jc.2012-1690 · DOI · Paper page
- Shaw, 2008, Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health—National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation, J Clin Endocrinol Metab, 93, 1276, 10.1210/jc.2007-0425 · DOI · Paper page
- Wild, 2000, Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study, Hum Fertil., 3, 101, 10.1080/1464727002000198781 · DOI · Paper page
- Unluturk, 2007, The genetic basis of the polycystic ovary syndrome: a literature review including discussion of PPAR-gamma, PPAR Res, 2007, 49109, 10.1155/2007/49109 · DOI · Paper page
- Alsamarai, 2009, Criteria for polycystic ovarian morphology in polycystic ovary syndrome as a function of age, J Clin Endocrinol Metab, 94, 4961, 10.1210/jc.2009-0839 · DOI · Paper page
- Armeni, 2019, Cardiovascular Risk in Postmenopausal Women with Polycystic Ovary Syndrome, Curr Vasc Pharmacol, 17, 579, 10.2174/1570161116666180828154006 · DOI
- Hernández-Reséndiz, 2018, Responses of endothelial cells towards ischemic conditioning following acute myocardial infarction, Cond Med., 1, 247
- Richardson, 2003, Current perspectives in polycystic ovary syndrome, Am Fam Physician, 68, 697
- Ueda-Nishimura, 2005, Synergic action of insulin and genistein on Na+/K+/2Cl- cotransporter in renal epithelium, Biochem Biophys Res Commun., 332, 1042, 10.1016/j.bbrc.2005.05.046 · DOI
Cited by
Stener-Victorin, E., Teede, H., Norman, R. J., Legro, R., Goodarzi, M. O., Dokras, A., Laven, J., Hoeger, K., & Piltonen, T. T. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00511-3 · Cited by 495
“Mortality data in PCOS is mixed 72–74 , but a large register study reports increased overall mortality in PCOS 50 , with contributions from cardiovascular outcomes and endometrial cancer.”
Berni, T. R., Morgan, C. L., & Rees, D. A. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab392 · Cited by 146
“Our finding of an increased risk of cardiovascular events is consistent with some (11, 24, 29, 30, 31), but not all (12, 32), previous meta-analyses which have examined the risk of coronary heart disease, stroke and/or cardiovascular mortality in this population.”
ResultDietary Patterns and Metabolic and Hormonal Parameters in Women with Suspected PCOS
Kowalczyk, K., Kadłubek, S., Krużel, A., Sikora, D., Daniluk, J., & Madej, P. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14082708 · Cited by 4
“While PCOS is often associated with reproductive issues, it is crucial to understand that it also significantly increases the risk of metabolic disorders, including dyslipidemia which can lead to severe cardiovascular problems in the future [9,10].”
Metadata
- Authors
- Zhang, J., Xu, J.-H., Qu, Q.-Q., & Zhong, G.-Q.
- Venue
- Frontiers in Cardiovascular Medicine
- Publisher
- Frontiers Media SA
- Published
- 2020-11-12
- Volume
- 7
- Pages
- 552421-552421
- ISSN
- 2297-055X (ISSN-L)
- OpenAlex
- W3098746485
- Cited by
- 96
- References
- 18
- FWCI
- 2.52
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.